SQUARE has invested in state of the art formulation plants aligned to regulated market standards. Six manufacturing units of the Dhaka site can produce pharmaceutical products maintaining cGMP requirement for highly regulated markets in Europe, Australia and USA. Other five manufacturing units at Pabna site are producing finished formulations targeting markets in ASEAN, SAARC and marketing in RoW region. We have 700 product approvals for export markets and 900 product approvals for Bangladesh market.

Present Markets

SQUARE Pharmaceuticals Ltd. is already supplying products to the following markets:

Europe: UK

Asia: Afghanistan, Bhutan, Cambodia, Fiji, Hong Kong, Iraq, Macau, Malaysia, Maldives, Myanmar, Nepal, Papua New Guinea, Sri Lanka, Tajikistan, The Philippines, Uzbekistan, Vietnam

Africa: Eritrea, Gambia, Ghana, Ivory Coast, Kenya, Libya, Malawi, Mauritania, Mauritius, Mozambique, Niger, Nigeria, Sierra Leone, Somalia, Tanzania, Uganda

Central and South America: Belize, Costa Rica, Suriname

Highlights of the Export Operations

• Exports pharmaceutical finished products since 1995


• Offers quality products at competitive price


• Offers more than 300 off-patent and on-patent molecules in different dosage forms


• Offers facilities for contract manufacturing


• Offers services for product development with subsequent technology transfer


• Provides assistance in product promotion and training in overseas markets